Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ukko

Biotech & Life Sciences · Rehovot, Israel · Founded 2016

Ukko is a pioneering company focused on addressing food allergies and sensitivities, particularly gluten-related disorders. The company operates in the biotechnology and healthcare markets, leveraging cutting-edge technologies in immunology, computational biology, and protein engineering. Ukko's core business involves mapping the molecular structure of food allergies and disorders to understand the biological mechanisms driving human food interactions. This comprehensive, clinically validated map enables Ukko to design proteins that do not trigger immune responses, which are then applied to both food and therapeutic markets. Ukko serves a diverse range of clients, including individuals suffering from food allergies and gluten-related disorders, healthcare providers, and food manufacturers. The company’s business model is centered around the development and commercialization of these specialized proteins. Revenue is generated through the sale of these proteins to food manufacturers and healthcare providers, as well as through partnerships and licensing agreements. Ukko's innovative approach aims to reduce the significant social, health, and economic impacts associated with food allergies and gluten disorders, which are on the rise globally. Keywords: food allergies, gluten disorders, immunology, computational biology, protein engineering, biotechnology, healthcare, molecular mapping, therapeutic proteins, food safety.

Valuation
$100–500M
Latest valuation · 2024
Unlock exact value
Headcount
<100
Current team size
Unlock exact value
Total funding Pre-IPO
$50–100M
Unlock exact value

Investors

11 investors on Ukko's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 11 investors entered at this stage
Khosla Ventures
Slow Ventures
Innovation Endeavors
Marc Benioff
Izhar Armony
Leaps by Bayer
Skyviews Life Science
Fall Line Capital
Continental Grain
PeakBridge
Time Ventures

Global footprint

Where Ukko has talent and traffic

Workforce by country
2 countries with
team presence
🇮🇱 Israel70.4%
🇺🇸 United States29.6%
2 countries shown

Talent graph

The shape of Ukko's talent

Dealroom maps Ukko's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 team members profilednamed & role-tagged by Dealroom
58 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Ukko's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Ukko

An AI-synthesized read of the highest-engagement posts about Ukko on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ukko on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.